Advertisement

Index by author

June 01, 1991; Volume 257,Issue 3

A

  1. Ambrose, J R

    1. The relative efficiency of beta adrenoceptor coupling to myocardial inotropy and diastolic relaxation: organ-selective treatment for diastolic dysfunction.
      T P Kenakin, J R Ambrose and P E Irving
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1189-1197;

  2. Anderson, B D

    1. Probenecid enhances central nervous system uptake of 2',3'-dideoxyinosine by inhibiting cerebrospinal fluid efflux.
      R E Galinsky, K K Flaharty, B L Hoesterey and B D Anderson
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 972-978;

  3. Anderson, D J

    1. Pharmacological profiles for rat cortical M1 and M2 muscarinic receptors using selective antagonists: comparison with N1E-115 muscarinic receptors.
      M McKinney, D J Anderson, L Vella-Rountree, T Connolly and J H Miller
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1121-1129;

  4. Andrade, R

    1. 5-Hydroxytryptamine4-like receptors mediate the slow excitatory response to serotonin in the rat hippocampus.
      R Andrade and Y Chaput
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 930-937;

B

  1. Ballati, L

    1. In vivo evidence for tachykininergic transmission using a new NK-2 receptor-selective antagonist, MEN 10,376.
      C A Maggi, S Giuliani, L Ballati, A Lecci, S Manzini, R Patacchini, A R Renzetti, P Rovero, L Quartara and A Giachetti
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1172-1178;

  2. Barzizza, A

    1. Activation of presynaptic 5-hydroxytryptamine1-like receptors on glutamatergic terminals inhibits N-methyl-D-aspartate-induced cyclic GMP production in rat cerebellar slices.
      M Raiteri, G Maura and A Barzizza
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1184-1188;

  3. Beil, M

    1. Renal actions of a new adenosine agonist, CGS 21680A selective for the A2 receptor.
      N Levens, M Beil and M Jarvis
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1005-1012;
    2. Intrarenal actions of the new adenosine agonist CGS 21680A, selective for the A2 receptor.
      N Levens, M Beil and R Schulz
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1013-1019;

  4. Bencherif, M

    1. Ligand binding and functional characterization of muscarinic acetylcholine receptors on the TE671/RD human cell line.
      M Bencherif and R J Lukas
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 946-953;

  5. Bing, Z

    1. Depressive effects of mu and delta opioid receptor agonists on activities of dorsal horn neurones are enhanced by dibencozide.
      L Villanueva, Z Bing, D Bouhassira and D Le Bars
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1198-1202;

  6. Bjercke, R J

    1. Characterization of nicotinic receptors on cultured cortical neurons using anti-idiotypic antibodies and ligand binding.
      P M Lippiello, K G Fernandes, J J Langone and R J Bjercke
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1216-1224;

  7. Blier, P

    1. Effects of long-term desipramine administration on noradrenergic neurotransmission: electrophysiological studies in the rat brain.
      D Lacroix, P Blier, O Curet and C de Montigny
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1081-1090;

  8. Boja, J W

    1. In vivo labeling of cocaine binding sites on dopamine transporters with [3H]WIN 35,428.
      U Scheffel, S Pögün, M Stathis, J W Boja and M J Kuhar
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 954-958;

  9. Bouhassira, D

    1. Depressive effects of mu and delta opioid receptor agonists on activities of dorsal horn neurones are enhanced by dibencozide.
      L Villanueva, Z Bing, D Bouhassira and D Le Bars
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1198-1202;

  10. Bowen, W D

    1. Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes.
      Q Jiang, A E Takemori, M Sultana, P S Portoghese, W D Bowen, H I Mosberg and F Porreca
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1069-1075;

  11. Brass, E P

    1. Effect of clofibrate treatment on hepatic prostaglandin catabolism and action.
      E P Brass and L J Ruff
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1034-1038;

  12. Brenneman, D E

    1. An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system.
      I Gozes, S K McCune, L Jacobson, D Warren, T W Moody, M Fridkin and D E Brenneman
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 959-966;

  13. Brooks, D P

    1. Attenuation of amphotericin B nephrotoxicity in the dog by the fenoldopam prodrug, SK&F R-105058.
      D P Brooks, M P Mitchell, B G Short, R R Ruffolo and A J Nichols
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1243-1247;

  14. Buck, K J

    1. Reversal of alcohol dependence and tolerance by a single administration of flumazenil.
      K J Buck, H Heim and R A Harris
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 984-989;

C

  1. Cass, W A

    1. Inhibitors of arachidonic acid metabolism: effects on rat striatal dopamine release and uptake.
      W A Cass, G Larson, F A Fitzpatrick and N R Zahniser
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 990-996;

  2. Chaput, Y

    1. 5-Hydroxytryptamine4-like receptors mediate the slow excitatory response to serotonin in the rat hippocampus.
      R Andrade and Y Chaput
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 930-937;

  3. Chaudhuri, G

    1. Comparison of the inhibitory potencies of N(G)-methyl-, N(G)-nitro- and N(G)-amino-L-arginine on EDRF function in the rat: evidence for continuous basal EDRF release.
      H M Vargas, J M Cuevas, L J Ignarro and G Chaudhuri
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1208-1215;

  4. Cheung, D W

    1. An electrophysiological study on the effect of neuropeptide Y on sympathetic neurotransmission in guinea pig vas deferens.
      D W Cheung and R Dukkipati
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 979-983;

  5. Chuang, D M

    1. Endothelin- and sarafotoxin-induced phosphoinositide hydrolysis in cultured cerebellar granule cells: biochemical and pharmacological characterization.
      W W Lin, C Y Lee and D M Chuang
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1053-1061;

  6. Connolly, T

    1. Pharmacological profiles for rat cortical M1 and M2 muscarinic receptors using selective antagonists: comparison with N1E-115 muscarinic receptors.
      M McKinney, D J Anderson, L Vella-Rountree, T Connolly and J H Miller
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1121-1129;

  7. Cordeiro, R S

    1. Generation of an eosinophilotactic activity in the pleural cavity of platelet-activating factor-injected rats.
      P M e Silva, M A Martins, H C Faria Neto, R S Cordeiro and B B Vargaftig
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1039-1044;

  8. Costa, E

    1. The preferential antagonism of pentylenetetrazole proconflict responses differentiates a class of anxiolytic benzodiazepines with potential antipanic action.
      P Giusti, G Guidetti, E Costa and A Guidotti
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1062-1068;

  9. Crawley, J N

    1. Centrally administered cholecystokinin suppresses feeding through a peripheral-type receptor mechanism.
      J N Crawley, S M Fiske, C Durieux, M Derrien and B P Roques
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1076-1080;

  10. Cuevas, J M

    1. Comparison of the inhibitory potencies of N(G)-methyl-, N(G)-nitro- and N(G)-amino-L-arginine on EDRF function in the rat: evidence for continuous basal EDRF release.
      H M Vargas, J M Cuevas, L J Ignarro and G Chaudhuri
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1208-1215;

  11. Curet, O

    1. Effects of long-term desipramine administration on noradrenergic neurotransmission: electrophysiological studies in the rat brain.
      D Lacroix, P Blier, O Curet and C de Montigny
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1081-1090;

  12. Cushman, D W

    1. Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection.
      G J Grover, P G Sleph, S Dzwonczyk, P Wang, W Fung, D Tobias and D W Cushman
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 919-929;

D

  1. de Costa, B R

    1. Differential antagonism of U69,593- and bremazocine-induced antinociception by (-)-UPHIT: evidence of kappa opioid receptor multiplicity in mice.
      P Horan, B R de Costa, K C Rice and F Porreca
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1154-1161;

  2. de Montigny, C

    1. Effects of long-term desipramine administration on noradrenergic neurotransmission: electrophysiological studies in the rat brain.
      D Lacroix, P Blier, O Curet and C de Montigny
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1081-1090;

  3. Derrien, M

    1. Centrally administered cholecystokinin suppresses feeding through a peripheral-type receptor mechanism.
      J N Crawley, S M Fiske, C Durieux, M Derrien and B P Roques
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1076-1080;

  4. Drummond, G S

    1. Tin(Sn+4)-diiododeuteroporphyrin; an in vitro and in vivo inhibitor of heme oxygenase with substantially reduced photoactive properties.
      G S Drummond, N L Greenbaum and A Kappas
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1109-1113;

  5. Dukkipati, R

    1. An electrophysiological study on the effect of neuropeptide Y on sympathetic neurotransmission in guinea pig vas deferens.
      D W Cheung and R Dukkipati
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 979-983;

  6. Durieux, C

    1. Centrally administered cholecystokinin suppresses feeding through a peripheral-type receptor mechanism.
      J N Crawley, S M Fiske, C Durieux, M Derrien and B P Roques
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1076-1080;

  7. Dzwonczyk, S

    1. Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection.
      G J Grover, P G Sleph, S Dzwonczyk, P Wang, W Fung, D Tobias and D W Cushman
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 919-929;

E

  1. Edwards, R M

    1. Calcitonin gene-related peptide stimulates adenylate cyclase and relaxes intracerebral arterioles.
      R M Edwards, E J Stack and W Trizna
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1020-1024;

  2. el-Fakahany, E E

    1. Effects of agonist efficacy on desensitization of phosphoinositide hydrolysis mediated by m1 and m3 muscarinic receptors expressed in Chinese hamster ovary cells.
      J Hu, S Z Wang and E E el-Fakahany
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 938-945;

  3. e Silva, P M

    1. Generation of an eosinophilotactic activity in the pleural cavity of platelet-activating factor-injected rats.
      P M e Silva, M A Martins, H C Faria Neto, R S Cordeiro and B B Vargaftig
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1039-1044;

  4. Eydelloth, R S

    1. HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies.
      P F Smith, R S Eydelloth, S J Grossman, R J Stubbs, M S Schwartz, J I Germershausen, K P Vyas, P H Kari and J S MacDonald
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1225-1235;

F

  1. Faria Neto, H C

    1. Generation of an eosinophilotactic activity in the pleural cavity of platelet-activating factor-injected rats.
      P M e Silva, M A Martins, H C Faria Neto, R S Cordeiro and B B Vargaftig
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1039-1044;

  2. Farley, J M

    1. Spontaneous transient outward currents and Ca(++)-activated K+ channels in swine tracheal smooth muscle cells.
      H M Saunders and J M Farley
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1114-1120;

  3. Felder, C C

    1. The antiproliferative and antimetastatic compound L651582 inhibits muscarinic acetylcholine receptor-stimulated calcium influx and arachidonic acid release.
      C C Felder, A L Ma, L A Liotta and E C Kohn
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 967-971;

  4. Fernandes, K G

    1. Characterization of nicotinic receptors on cultured cortical neurons using anti-idiotypic antibodies and ligand binding.
      P M Lippiello, K G Fernandes, J J Langone and R J Bjercke
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1216-1224;

  5. Ferrier, G R

    1. Effects of lidocaine on reperfusion arrhythmias and electrophysiological properties in an isolated ventricular muscle model of ischemia and reperfusion.
      G R Li and G R Ferrier
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 997-1004;

  6. Fiske, S M

    1. Centrally administered cholecystokinin suppresses feeding through a peripheral-type receptor mechanism.
      J N Crawley, S M Fiske, C Durieux, M Derrien and B P Roques
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1076-1080;

  7. Fitzpatrick, F A

    1. Inhibitors of arachidonic acid metabolism: effects on rat striatal dopamine release and uptake.
      W A Cass, G Larson, F A Fitzpatrick and N R Zahniser
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 990-996;

  8. Flaharty, K K

    1. Probenecid enhances central nervous system uptake of 2',3'-dideoxyinosine by inhibiting cerebrospinal fluid efflux.
      R E Galinsky, K K Flaharty, B L Hoesterey and B D Anderson
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 972-978;

  9. Fridkin, M

    1. An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system.
      I Gozes, S K McCune, L Jacobson, D Warren, T W Moody, M Fridkin and D E Brenneman
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 959-966;

  10. Fujimoto, J M

    1. Isobolographic analysis of analgesic interactions between intrathecally and intracerebroventricularly administered fentanyl, morphine and D-Ala2-D-Leu5-enkephalin in morphine-tolerant and nontolerant mice.
      S C Roerig, R G Hoffman, A E Takemori, G L Wilcox and J M Fujimoto
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1091-1099;

  11. Fung, W

    1. Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection.
      G J Grover, P G Sleph, S Dzwonczyk, P Wang, W Fung, D Tobias and D W Cushman
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 919-929;

G

  1. Galinsky, R E

    1. Probenecid enhances central nervous system uptake of 2',3'-dideoxyinosine by inhibiting cerebrospinal fluid efflux.
      R E Galinsky, K K Flaharty, B L Hoesterey and B D Anderson
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 972-978;

  2. Galligan, J J

    1. Erythromycin inhibits contractions of nerve-muscle preparations of the guinea pig small intestine.
      A Minocha and J J Galligan
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1248-1252;

  3. Germershausen, J I

    1. HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies.
      P F Smith, R S Eydelloth, S J Grossman, R J Stubbs, M S Schwartz, J I Germershausen, K P Vyas, P H Kari and J S MacDonald
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1225-1235;

  4. Giachetti, A

    1. In vivo evidence for tachykininergic transmission using a new NK-2 receptor-selective antagonist, MEN 10,376.
      C A Maggi, S Giuliani, L Ballati, A Lecci, S Manzini, R Patacchini, A R Renzetti, P Rovero, L Quartara and A Giachetti
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1172-1178;

  5. Giuliani, S

    1. In vivo evidence for tachykininergic transmission using a new NK-2 receptor-selective antagonist, MEN 10,376.
      C A Maggi, S Giuliani, L Ballati, A Lecci, S Manzini, R Patacchini, A R Renzetti, P Rovero, L Quartara and A Giachetti
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1172-1178;

  6. Giusti, P

    1. The preferential antagonism of pentylenetetrazole proconflict responses differentiates a class of anxiolytic benzodiazepines with potential antipanic action.
      P Giusti, G Guidetti, E Costa and A Guidotti
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1062-1068;

  7. Goldschmidt, J E

    1. Pharmacological evidence that captopril possesses an endothelium-mediated component of vasodilation: effect of sulfhydryl groups on endothelium-derived relaxing factor.
      J E Goldschmidt and R J Tallarida
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1136-1145;

  8. Gopalakrishnan, M

    1. Characterization of binding of the ATP-sensitive potassium channel ligand, [3H]glyburide, to neuronal and muscle preparations.
      M Gopalakrishnan, D E Johnson, R A Janis and D J Triggle
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1162-1171;

  9. Gotoh, K

    1. Enhanced antitumor activity in mice after administration of thermosensitive liposome encapsulating cisplatin with hyperthermia.
      K Iga, N Hamaguchi, Y Igari, Y Ogawa, K Gotoh, K Ootsu, H Toguchi and T Shimamoto
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1203-1207;

  10. Gozes, I

    1. An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system.
      I Gozes, S K McCune, L Jacobson, D Warren, T W Moody, M Fridkin and D E Brenneman
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 959-966;

  11. Greenbaum, N L

    1. Tin(Sn+4)-diiododeuteroporphyrin; an in vitro and in vivo inhibitor of heme oxygenase with substantially reduced photoactive properties.
      G S Drummond, N L Greenbaum and A Kappas
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1109-1113;

  12. Grossman, S J

    1. HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies.
      P F Smith, R S Eydelloth, S J Grossman, R J Stubbs, M S Schwartz, J I Germershausen, K P Vyas, P H Kari and J S MacDonald
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1225-1235;

  13. Grover, G J

    1. Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection.
      G J Grover, P G Sleph, S Dzwonczyk, P Wang, W Fung, D Tobias and D W Cushman
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 919-929;

  14. Guidetti, G

    1. The preferential antagonism of pentylenetetrazole proconflict responses differentiates a class of anxiolytic benzodiazepines with potential antipanic action.
      P Giusti, G Guidetti, E Costa and A Guidotti
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1062-1068;

  15. Guidotti, A

    1. The preferential antagonism of pentylenetetrazole proconflict responses differentiates a class of anxiolytic benzodiazepines with potential antipanic action.
      P Giusti, G Guidetti, E Costa and A Guidotti
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1062-1068;

H

  1. Hamaguchi, N

    1. Enhanced antitumor activity in mice after administration of thermosensitive liposome encapsulating cisplatin with hyperthermia.
      K Iga, N Hamaguchi, Y Igari, Y Ogawa, K Gotoh, K Ootsu, H Toguchi and T Shimamoto
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1203-1207;

  2. Harris, R A

    1. Reversal of alcohol dependence and tolerance by a single administration of flumazenil.
      K J Buck, H Heim and R A Harris
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 984-989;

  3. Heim, H

    1. Reversal of alcohol dependence and tolerance by a single administration of flumazenil.
      K J Buck, H Heim and R A Harris
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 984-989;

  4. Heim, K F

    1. Effect of substituted arginine compounds on superoxide production in the rabbit aorta.
      K F Heim, G Thomas and P W Ramwell
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1130-1135;

  5. Hieble, J P

    1. Lack of a pharmacological distinction between alpha-1 adrenoceptors mediating intracellular calcium-dependent and independent contractions to sympathetic nerve stimulation in the perfused rat caudal artery.
      A Sulpizio and J P Hieble
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1045-1052;

  6. Hoesterey, B L

    1. Probenecid enhances central nervous system uptake of 2',3'-dideoxyinosine by inhibiting cerebrospinal fluid efflux.
      R E Galinsky, K K Flaharty, B L Hoesterey and B D Anderson
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 972-978;

  7. Hoffman, R G

    1. Isobolographic analysis of analgesic interactions between intrathecally and intracerebroventricularly administered fentanyl, morphine and D-Ala2-D-Leu5-enkephalin in morphine-tolerant and nontolerant mice.
      S C Roerig, R G Hoffman, A E Takemori, G L Wilcox and J M Fujimoto
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1091-1099;

  8. Holst, M

    1. Effect of the ANF analog A68828 in cisplatin-induced acute renal failure.
      D M Pollock, M Holst and T J Opgenorth
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1179-1183;

  9. Hönack, D

    1. The novel competitive N-methyl-D-aspartate (NMDA) antagonist CGP 37849 preferentially induces phencyclidine-like behavioral effects in kindled rats: attenuation by manipulation of dopamine, alpha-1 and serotonin1A receptors.
      W Löscher and D Hönack
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1146-1153;

  10. Horan, P

    1. Differential antagonism of U69,593- and bremazocine-induced antinociception by (-)-UPHIT: evidence of kappa opioid receptor multiplicity in mice.
      P Horan, B R de Costa, K C Rice and F Porreca
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1154-1161;

  11. Hu, J

    1. Effects of agonist efficacy on desensitization of phosphoinositide hydrolysis mediated by m1 and m3 muscarinic receptors expressed in Chinese hamster ovary cells.
      J Hu, S Z Wang and E E el-Fakahany
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 938-945;

I

  1. Iga, K

    1. Enhanced antitumor activity in mice after administration of thermosensitive liposome encapsulating cisplatin with hyperthermia.
      K Iga, N Hamaguchi, Y Igari, Y Ogawa, K Gotoh, K Ootsu, H Toguchi and T Shimamoto
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1203-1207;

  2. Igari, Y

    1. Enhanced antitumor activity in mice after administration of thermosensitive liposome encapsulating cisplatin with hyperthermia.
      K Iga, N Hamaguchi, Y Igari, Y Ogawa, K Gotoh, K Ootsu, H Toguchi and T Shimamoto
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1203-1207;

  3. Ignarro, L J

    1. Comparison of the inhibitory potencies of N(G)-methyl-, N(G)-nitro- and N(G)-amino-L-arginine on EDRF function in the rat: evidence for continuous basal EDRF release.
      H M Vargas, J M Cuevas, L J Ignarro and G Chaudhuri
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1208-1215;

  4. Irving, P E

    1. The relative efficiency of beta adrenoceptor coupling to myocardial inotropy and diastolic relaxation: organ-selective treatment for diastolic dysfunction.
      T P Kenakin, J R Ambrose and P E Irving
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1189-1197;

J

  1. Jacobson, L

    1. An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system.
      I Gozes, S K McCune, L Jacobson, D Warren, T W Moody, M Fridkin and D E Brenneman
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 959-966;

  2. Janis, R A

    1. Characterization of binding of the ATP-sensitive potassium channel ligand, [3H]glyburide, to neuronal and muscle preparations.
      M Gopalakrishnan, D E Johnson, R A Janis and D J Triggle
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1162-1171;

  3. Janowsky, A

    1. Characterization and distribution of [125I]epidepride binding to dopamine D2 receptors in basal ganglia and cortex of human brain.
      J N Joyce, A Janowsky and K A Neve
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1253-1263;

  4. Jarvis, M

    1. Renal actions of a new adenosine agonist, CGS 21680A selective for the A2 receptor.
      N Levens, M Beil and M Jarvis
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1005-1012;

  5. Jhamandas, K

    1. Met-enkephalin release from slices of the rat striatum and globus pallidus: stimulation by excitatory amino acids.
      B B Ruzicka and K Jhamandas
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1025-1033;

  6. Jiang, Q

    1. Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes.
      Q Jiang, A E Takemori, M Sultana, P S Portoghese, W D Bowen, H I Mosberg and F Porreca
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1069-1075;

  7. Johnson, D E

    1. Characterization of binding of the ATP-sensitive potassium channel ligand, [3H]glyburide, to neuronal and muscle preparations.
      M Gopalakrishnan, D E Johnson, R A Janis and D J Triggle
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1162-1171;

  8. Joyce, J N

    1. Characterization and distribution of [125I]epidepride binding to dopamine D2 receptors in basal ganglia and cortex of human brain.
      J N Joyce, A Janowsky and K A Neve
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1253-1263;

K

  1. Kappas, A

    1. Tin(Sn+4)-diiododeuteroporphyrin; an in vitro and in vivo inhibitor of heme oxygenase with substantially reduced photoactive properties.
      G S Drummond, N L Greenbaum and A Kappas
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1109-1113;

  2. Kari, P H

    1. HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies.
      P F Smith, R S Eydelloth, S J Grossman, R J Stubbs, M S Schwartz, J I Germershausen, K P Vyas, P H Kari and J S MacDonald
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1225-1235;

  3. Kenakin, T P

    1. The relative efficiency of beta adrenoceptor coupling to myocardial inotropy and diastolic relaxation: organ-selective treatment for diastolic dysfunction.
      T P Kenakin, J R Ambrose and P E Irving
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1189-1197;

  4. Kohn, E C

    1. The antiproliferative and antimetastatic compound L651582 inhibits muscarinic acetylcholine receptor-stimulated calcium influx and arachidonic acid release.
      C C Felder, A L Ma, L A Liotta and E C Kohn
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 967-971;

  5. Kuhar, M J

    1. In vivo labeling of cocaine binding sites on dopamine transporters with [3H]WIN 35,428.
      U Scheffel, S Pögün, M Stathis, J W Boja and M J Kuhar
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 954-958;

L

  1. Lacroix, D

    1. Effects of long-term desipramine administration on noradrenergic neurotransmission: electrophysiological studies in the rat brain.
      D Lacroix, P Blier, O Curet and C de Montigny
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1081-1090;

  2. Langone, J J

    1. Characterization of nicotinic receptors on cultured cortical neurons using anti-idiotypic antibodies and ligand binding.
      P M Lippiello, K G Fernandes, J J Langone and R J Bjercke
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1216-1224;

  3. Larson, G

    1. Inhibitors of arachidonic acid metabolism: effects on rat striatal dopamine release and uptake.
      W A Cass, G Larson, F A Fitzpatrick and N R Zahniser
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 990-996;

  4. Latifpour, J

    1. Pharmacological characterization of alpha adrenergic receptors in the young and old female rabbit urethra.
      M Yoshida, J Latifpour, T Nishimoto and R M Weiss
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1100-1108;

  5. Le Bars, D

    1. Depressive effects of mu and delta opioid receptor agonists on activities of dorsal horn neurones are enhanced by dibencozide.
      L Villanueva, Z Bing, D Bouhassira and D Le Bars
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1198-1202;

  6. Lecci, A

    1. In vivo evidence for tachykininergic transmission using a new NK-2 receptor-selective antagonist, MEN 10,376.
      C A Maggi, S Giuliani, L Ballati, A Lecci, S Manzini, R Patacchini, A R Renzetti, P Rovero, L Quartara and A Giachetti
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1172-1178;

  7. Lee, C Y

    1. Endothelin- and sarafotoxin-induced phosphoinositide hydrolysis in cultured cerebellar granule cells: biochemical and pharmacological characterization.
      W W Lin, C Y Lee and D M Chuang
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1053-1061;

  8. Levens, N

    1. Renal actions of a new adenosine agonist, CGS 21680A selective for the A2 receptor.
      N Levens, M Beil and M Jarvis
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1005-1012;
    2. Intrarenal actions of the new adenosine agonist CGS 21680A, selective for the A2 receptor.
      N Levens, M Beil and R Schulz
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1013-1019;

  9. Li, G R

    1. Effects of lidocaine on reperfusion arrhythmias and electrophysiological properties in an isolated ventricular muscle model of ischemia and reperfusion.
      G R Li and G R Ferrier
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 997-1004;

  10. Lin, W W

    1. Endothelin- and sarafotoxin-induced phosphoinositide hydrolysis in cultured cerebellar granule cells: biochemical and pharmacological characterization.
      W W Lin, C Y Lee and D M Chuang
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1053-1061;

  11. Liotta, L A

    1. The antiproliferative and antimetastatic compound L651582 inhibits muscarinic acetylcholine receptor-stimulated calcium influx and arachidonic acid release.
      C C Felder, A L Ma, L A Liotta and E C Kohn
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 967-971;

  12. Lippiello, P M

    1. Characterization of nicotinic receptors on cultured cortical neurons using anti-idiotypic antibodies and ligand binding.
      P M Lippiello, K G Fernandes, J J Langone and R J Bjercke
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1216-1224;

  13. Löscher, W

    1. The novel competitive N-methyl-D-aspartate (NMDA) antagonist CGP 37849 preferentially induces phencyclidine-like behavioral effects in kindled rats: attenuation by manipulation of dopamine, alpha-1 and serotonin1A receptors.
      W Löscher and D Hönack
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1146-1153;

  14. Lukas, R J

    1. Ligand binding and functional characterization of muscarinic acetylcholine receptors on the TE671/RD human cell line.
      M Bencherif and R J Lukas
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 946-953;

M

  1. Ma, A L

    1. The antiproliferative and antimetastatic compound L651582 inhibits muscarinic acetylcholine receptor-stimulated calcium influx and arachidonic acid release.
      C C Felder, A L Ma, L A Liotta and E C Kohn
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 967-971;

  2. MacDonald, J S

    1. HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies.
      P F Smith, R S Eydelloth, S J Grossman, R J Stubbs, M S Schwartz, J I Germershausen, K P Vyas, P H Kari and J S MacDonald
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1225-1235;

  3. Maggi, C A

    1. In vivo evidence for tachykininergic transmission using a new NK-2 receptor-selective antagonist, MEN 10,376.
      C A Maggi, S Giuliani, L Ballati, A Lecci, S Manzini, R Patacchini, A R Renzetti, P Rovero, L Quartara and A Giachetti
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1172-1178;

  4. Manzini, S

    1. In vivo evidence for tachykininergic transmission using a new NK-2 receptor-selective antagonist, MEN 10,376.
      C A Maggi, S Giuliani, L Ballati, A Lecci, S Manzini, R Patacchini, A R Renzetti, P Rovero, L Quartara and A Giachetti
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1172-1178;

  5. Martins, M A

    1. Generation of an eosinophilotactic activity in the pleural cavity of platelet-activating factor-injected rats.
      P M e Silva, M A Martins, H C Faria Neto, R S Cordeiro and B B Vargaftig
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1039-1044;

  6. Maura, G

    1. Activation of presynaptic 5-hydroxytryptamine1-like receptors on glutamatergic terminals inhibits N-methyl-D-aspartate-induced cyclic GMP production in rat cerebellar slices.
      M Raiteri, G Maura and A Barzizza
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1184-1188;

  7. McCune, S K

    1. An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system.
      I Gozes, S K McCune, L Jacobson, D Warren, T W Moody, M Fridkin and D E Brenneman
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 959-966;

  8. McKinney, M

    1. Pharmacological profiles for rat cortical M1 and M2 muscarinic receptors using selective antagonists: comparison with N1E-115 muscarinic receptors.
      M McKinney, D J Anderson, L Vella-Rountree, T Connolly and J H Miller
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1121-1129;

  9. Miller, J H

    1. Pharmacological profiles for rat cortical M1 and M2 muscarinic receptors using selective antagonists: comparison with N1E-115 muscarinic receptors.
      M McKinney, D J Anderson, L Vella-Rountree, T Connolly and J H Miller
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1121-1129;

  10. Minocha, A

    1. Erythromycin inhibits contractions of nerve-muscle preparations of the guinea pig small intestine.
      A Minocha and J J Galligan
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1248-1252;

  11. Mitchell, M P

    1. Attenuation of amphotericin B nephrotoxicity in the dog by the fenoldopam prodrug, SK&F R-105058.
      D P Brooks, M P Mitchell, B G Short, R R Ruffolo and A J Nichols
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1243-1247;

  12. Moody, T W

    1. An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system.
      I Gozes, S K McCune, L Jacobson, D Warren, T W Moody, M Fridkin and D E Brenneman
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 959-966;

  13. Mosberg, H I

    1. Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes.
      Q Jiang, A E Takemori, M Sultana, P S Portoghese, W D Bowen, H I Mosberg and F Porreca
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1069-1075;

N

  1. Neve, K A

    1. Characterization and distribution of [125I]epidepride binding to dopamine D2 receptors in basal ganglia and cortex of human brain.
      J N Joyce, A Janowsky and K A Neve
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1253-1263;

  2. Nichols, A J

    1. Attenuation of amphotericin B nephrotoxicity in the dog by the fenoldopam prodrug, SK&F R-105058.
      D P Brooks, M P Mitchell, B G Short, R R Ruffolo and A J Nichols
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1243-1247;

  3. Nishimoto, T

    1. Pharmacological characterization of alpha adrenergic receptors in the young and old female rabbit urethra.
      M Yoshida, J Latifpour, T Nishimoto and R M Weiss
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1100-1108;

O

  1. Ogawa, Y

    1. Enhanced antitumor activity in mice after administration of thermosensitive liposome encapsulating cisplatin with hyperthermia.
      K Iga, N Hamaguchi, Y Igari, Y Ogawa, K Gotoh, K Ootsu, H Toguchi and T Shimamoto
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1203-1207;

  2. Olsen, R W

    1. The benzodiazepine/alcohol antagonist Ro 15-4513: binding to a GABAA receptor subtype that is insensitive to diazepam.
      D M Turner, D W Sapp and R W Olsen
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1236-1242;

  3. Ootsu, K

    1. Enhanced antitumor activity in mice after administration of thermosensitive liposome encapsulating cisplatin with hyperthermia.
      K Iga, N Hamaguchi, Y Igari, Y Ogawa, K Gotoh, K Ootsu, H Toguchi and T Shimamoto
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1203-1207;

  4. Opgenorth, T J

    1. Effect of the ANF analog A68828 in cisplatin-induced acute renal failure.
      D M Pollock, M Holst and T J Opgenorth
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1179-1183;

P

  1. Patacchini, R

    1. In vivo evidence for tachykininergic transmission using a new NK-2 receptor-selective antagonist, MEN 10,376.
      C A Maggi, S Giuliani, L Ballati, A Lecci, S Manzini, R Patacchini, A R Renzetti, P Rovero, L Quartara and A Giachetti
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1172-1178;

  2. Pögün, S

    1. In vivo labeling of cocaine binding sites on dopamine transporters with [3H]WIN 35,428.
      U Scheffel, S Pögün, M Stathis, J W Boja and M J Kuhar
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 954-958;

  3. Pollock, D M

    1. Effect of the ANF analog A68828 in cisplatin-induced acute renal failure.
      D M Pollock, M Holst and T J Opgenorth
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1179-1183;

  4. Porreca, F

    1. Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes.
      Q Jiang, A E Takemori, M Sultana, P S Portoghese, W D Bowen, H I Mosberg and F Porreca
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1069-1075;
    2. Differential antagonism of U69,593- and bremazocine-induced antinociception by (-)-UPHIT: evidence of kappa opioid receptor multiplicity in mice.
      P Horan, B R de Costa, K C Rice and F Porreca
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1154-1161;

  5. Portoghese, P S

    1. Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes.
      Q Jiang, A E Takemori, M Sultana, P S Portoghese, W D Bowen, H I Mosberg and F Porreca
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1069-1075;

Q

  1. Quartara, L

    1. In vivo evidence for tachykininergic transmission using a new NK-2 receptor-selective antagonist, MEN 10,376.
      C A Maggi, S Giuliani, L Ballati, A Lecci, S Manzini, R Patacchini, A R Renzetti, P Rovero, L Quartara and A Giachetti
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1172-1178;

R

  1. Raiteri, M

    1. Activation of presynaptic 5-hydroxytryptamine1-like receptors on glutamatergic terminals inhibits N-methyl-D-aspartate-induced cyclic GMP production in rat cerebellar slices.
      M Raiteri, G Maura and A Barzizza
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1184-1188;

  2. Ramwell, P W

    1. Effect of substituted arginine compounds on superoxide production in the rabbit aorta.
      K F Heim, G Thomas and P W Ramwell
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1130-1135;

  3. Renzetti, A R

    1. In vivo evidence for tachykininergic transmission using a new NK-2 receptor-selective antagonist, MEN 10,376.
      C A Maggi, S Giuliani, L Ballati, A Lecci, S Manzini, R Patacchini, A R Renzetti, P Rovero, L Quartara and A Giachetti
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1172-1178;

  4. Rice, K C

    1. Differential antagonism of U69,593- and bremazocine-induced antinociception by (-)-UPHIT: evidence of kappa opioid receptor multiplicity in mice.
      P Horan, B R de Costa, K C Rice and F Porreca
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1154-1161;

  5. Roerig, S C

    1. Isobolographic analysis of analgesic interactions between intrathecally and intracerebroventricularly administered fentanyl, morphine and D-Ala2-D-Leu5-enkephalin in morphine-tolerant and nontolerant mice.
      S C Roerig, R G Hoffman, A E Takemori, G L Wilcox and J M Fujimoto
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1091-1099;

  6. Roques, B P

    1. Centrally administered cholecystokinin suppresses feeding through a peripheral-type receptor mechanism.
      J N Crawley, S M Fiske, C Durieux, M Derrien and B P Roques
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1076-1080;

  7. Rovero, P

    1. In vivo evidence for tachykininergic transmission using a new NK-2 receptor-selective antagonist, MEN 10,376.
      C A Maggi, S Giuliani, L Ballati, A Lecci, S Manzini, R Patacchini, A R Renzetti, P Rovero, L Quartara and A Giachetti
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1172-1178;

  8. Ruff, L J

    1. Effect of clofibrate treatment on hepatic prostaglandin catabolism and action.
      E P Brass and L J Ruff
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1034-1038;

  9. Ruffolo, R R

    1. Attenuation of amphotericin B nephrotoxicity in the dog by the fenoldopam prodrug, SK&F R-105058.
      D P Brooks, M P Mitchell, B G Short, R R Ruffolo and A J Nichols
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1243-1247;

  10. Ruzicka, B B

    1. Met-enkephalin release from slices of the rat striatum and globus pallidus: stimulation by excitatory amino acids.
      B B Ruzicka and K Jhamandas
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1025-1033;

S

  1. Sapp, D W

    1. The benzodiazepine/alcohol antagonist Ro 15-4513: binding to a GABAA receptor subtype that is insensitive to diazepam.
      D M Turner, D W Sapp and R W Olsen
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1236-1242;

  2. Saunders, H M

    1. Spontaneous transient outward currents and Ca(++)-activated K+ channels in swine tracheal smooth muscle cells.
      H M Saunders and J M Farley
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1114-1120;

  3. Scheffel, U

    1. In vivo labeling of cocaine binding sites on dopamine transporters with [3H]WIN 35,428.
      U Scheffel, S Pögün, M Stathis, J W Boja and M J Kuhar
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 954-958;

  4. Schulz, R

    1. Intrarenal actions of the new adenosine agonist CGS 21680A, selective for the A2 receptor.
      N Levens, M Beil and R Schulz
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1013-1019;

  5. Schwartz, M S

    1. HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies.
      P F Smith, R S Eydelloth, S J Grossman, R J Stubbs, M S Schwartz, J I Germershausen, K P Vyas, P H Kari and J S MacDonald
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1225-1235;

  6. Shimamoto, T

    1. Enhanced antitumor activity in mice after administration of thermosensitive liposome encapsulating cisplatin with hyperthermia.
      K Iga, N Hamaguchi, Y Igari, Y Ogawa, K Gotoh, K Ootsu, H Toguchi and T Shimamoto
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1203-1207;

  7. Short, B G

    1. Attenuation of amphotericin B nephrotoxicity in the dog by the fenoldopam prodrug, SK&F R-105058.
      D P Brooks, M P Mitchell, B G Short, R R Ruffolo and A J Nichols
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1243-1247;

  8. Sleph, P G

    1. Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection.
      G J Grover, P G Sleph, S Dzwonczyk, P Wang, W Fung, D Tobias and D W Cushman
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 919-929;

  9. Smith, P F

    1. HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies.
      P F Smith, R S Eydelloth, S J Grossman, R J Stubbs, M S Schwartz, J I Germershausen, K P Vyas, P H Kari and J S MacDonald
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1225-1235;

  10. Stack, E J

    1. Calcitonin gene-related peptide stimulates adenylate cyclase and relaxes intracerebral arterioles.
      R M Edwards, E J Stack and W Trizna
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1020-1024;

  11. Stathis, M

    1. In vivo labeling of cocaine binding sites on dopamine transporters with [3H]WIN 35,428.
      U Scheffel, S Pögün, M Stathis, J W Boja and M J Kuhar
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 954-958;

  12. Stubbs, R J

    1. HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies.
      P F Smith, R S Eydelloth, S J Grossman, R J Stubbs, M S Schwartz, J I Germershausen, K P Vyas, P H Kari and J S MacDonald
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1225-1235;

  13. Sulpizio, A

    1. Lack of a pharmacological distinction between alpha-1 adrenoceptors mediating intracellular calcium-dependent and independent contractions to sympathetic nerve stimulation in the perfused rat caudal artery.
      A Sulpizio and J P Hieble
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1045-1052;

  14. Sultana, M

    1. Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes.
      Q Jiang, A E Takemori, M Sultana, P S Portoghese, W D Bowen, H I Mosberg and F Porreca
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1069-1075;

T

  1. Takemori, A E

    1. Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes.
      Q Jiang, A E Takemori, M Sultana, P S Portoghese, W D Bowen, H I Mosberg and F Porreca
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1069-1075;
    2. Isobolographic analysis of analgesic interactions between intrathecally and intracerebroventricularly administered fentanyl, morphine and D-Ala2-D-Leu5-enkephalin in morphine-tolerant and nontolerant mice.
      S C Roerig, R G Hoffman, A E Takemori, G L Wilcox and J M Fujimoto
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1091-1099;

  2. Tallarida, R J

    1. Pharmacological evidence that captopril possesses an endothelium-mediated component of vasodilation: effect of sulfhydryl groups on endothelium-derived relaxing factor.
      J E Goldschmidt and R J Tallarida
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1136-1145;

  3. Thomas, G

    1. Effect of substituted arginine compounds on superoxide production in the rabbit aorta.
      K F Heim, G Thomas and P W Ramwell
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1130-1135;

  4. Tobias, D

    1. Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection.
      G J Grover, P G Sleph, S Dzwonczyk, P Wang, W Fung, D Tobias and D W Cushman
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 919-929;

  5. Toguchi, H

    1. Enhanced antitumor activity in mice after administration of thermosensitive liposome encapsulating cisplatin with hyperthermia.
      K Iga, N Hamaguchi, Y Igari, Y Ogawa, K Gotoh, K Ootsu, H Toguchi and T Shimamoto
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1203-1207;

  6. Triggle, D J

    1. Characterization of binding of the ATP-sensitive potassium channel ligand, [3H]glyburide, to neuronal and muscle preparations.
      M Gopalakrishnan, D E Johnson, R A Janis and D J Triggle
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1162-1171;

  7. Trizna, W

    1. Calcitonin gene-related peptide stimulates adenylate cyclase and relaxes intracerebral arterioles.
      R M Edwards, E J Stack and W Trizna
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1020-1024;

  8. Turner, D M

    1. The benzodiazepine/alcohol antagonist Ro 15-4513: binding to a GABAA receptor subtype that is insensitive to diazepam.
      D M Turner, D W Sapp and R W Olsen
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1236-1242;

V

  1. Vargaftig, B B

    1. Generation of an eosinophilotactic activity in the pleural cavity of platelet-activating factor-injected rats.
      P M e Silva, M A Martins, H C Faria Neto, R S Cordeiro and B B Vargaftig
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1039-1044;

  2. Vargas, H M

    1. Comparison of the inhibitory potencies of N(G)-methyl-, N(G)-nitro- and N(G)-amino-L-arginine on EDRF function in the rat: evidence for continuous basal EDRF release.
      H M Vargas, J M Cuevas, L J Ignarro and G Chaudhuri
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1208-1215;

  3. Vella-Rountree, L

    1. Pharmacological profiles for rat cortical M1 and M2 muscarinic receptors using selective antagonists: comparison with N1E-115 muscarinic receptors.
      M McKinney, D J Anderson, L Vella-Rountree, T Connolly and J H Miller
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1121-1129;

  4. Villanueva, L

    1. Depressive effects of mu and delta opioid receptor agonists on activities of dorsal horn neurones are enhanced by dibencozide.
      L Villanueva, Z Bing, D Bouhassira and D Le Bars
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1198-1202;

  5. Vyas, K P

    1. HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies.
      P F Smith, R S Eydelloth, S J Grossman, R J Stubbs, M S Schwartz, J I Germershausen, K P Vyas, P H Kari and J S MacDonald
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1225-1235;

W

  1. Wang, P

    1. Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection.
      G J Grover, P G Sleph, S Dzwonczyk, P Wang, W Fung, D Tobias and D W Cushman
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 919-929;

  2. Wang, S Z

    1. Effects of agonist efficacy on desensitization of phosphoinositide hydrolysis mediated by m1 and m3 muscarinic receptors expressed in Chinese hamster ovary cells.
      J Hu, S Z Wang and E E el-Fakahany
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 938-945;

  3. Warren, D

    1. An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system.
      I Gozes, S K McCune, L Jacobson, D Warren, T W Moody, M Fridkin and D E Brenneman
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 959-966;

  4. Weiss, R M

    1. Pharmacological characterization of alpha adrenergic receptors in the young and old female rabbit urethra.
      M Yoshida, J Latifpour, T Nishimoto and R M Weiss
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1100-1108;

  5. Wilcox, G L

    1. Isobolographic analysis of analgesic interactions between intrathecally and intracerebroventricularly administered fentanyl, morphine and D-Ala2-D-Leu5-enkephalin in morphine-tolerant and nontolerant mice.
      S C Roerig, R G Hoffman, A E Takemori, G L Wilcox and J M Fujimoto
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1091-1099;

Y

  1. Yoshida, M

    1. Pharmacological characterization of alpha adrenergic receptors in the young and old female rabbit urethra.
      M Yoshida, J Latifpour, T Nishimoto and R M Weiss
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1100-1108;

Z

  1. Zahniser, N R

    1. Inhibitors of arachidonic acid metabolism: effects on rat striatal dopamine release and uptake.
      W A Cass, G Larson, F A Fitzpatrick and N R Zahniser
      Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 990-996;
Back to top

In this issue

Advertisement